Sex differences in acute stroke metrics and outcome dependent on COVID status
- PMID: 38288522
- PMCID: PMC11235762
- DOI: 10.1111/ene.16221
Sex differences in acute stroke metrics and outcome dependent on COVID status
Abstract
Background and purpose: Biological sex is known to have an impact on quality metrics of acute stroke. We aimed to determine whether COVID positivity accentuates this effect and constitutes worse outcome.
Methods: The present analysis was based on the Global COVID-19 Stroke Registry, a retrospective, international, cohort study of consecutive ischemic stroke patients receiving intravenous thrombolysis and/or endovascular thrombectomy between 1 March 2020 and 30 June 2021. We investigated differences between the sexes in patient characteristics, acute stroke metrics as well as post-stroke outcome in COVID-positive and COVID-negative stroke patients undergoing acute revascularization procedures.
Results: A total of 15,128 patients from 106 centers were recorded in the Global COVID-19 Stroke Registry, 853 (5.6%) of whom were COVID-positive. Overall, COVID-positive individuals were treated significantly slower according to every acute stroke metric compared to COVID-negative patients. We were able to show that key quality indicators in acute stroke treatment were unfavorable for COVID-negative women compared to men (last-seen-well-to-door time + 11 min in women). Furthermore, COVID-negative women had worse 3-month outcomes (3-month modified Rankin Scale score [interquartile range] 3.0 [4.0] vs. 2.0 [3.0]; p < 0.01), even after adjusting for confounders. In COVID-positive individuals no such difference between the sexes, either in acute management metrics or in 3-month outcome, was seen.
Conclusion: Known sex-related differences in acute stroke management exist and extend to times of crisis. Nevertheless, if patients were COVID-19-positive at stroke onset, women and men were treated the same, which could be attributed to structured treatment pathways.
Keywords: COVID‐19; metrics; outcome; sex; stroke.
© 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Conflict of interest statement
The authors have stated explicitly that there are no conflicts of interest in connection with this article.
Figures
Similar articles
-
Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.Stroke. 2024 Jan;55(1):78-88. doi: 10.1161/STROKEAHA.123.043899. Epub 2023 Dec 22. Stroke. 2024. PMID: 38134260 Free PMC article.
-
Sex differences in onset to hospital arrival time, prestroke disability, and clinical symptoms in patients with a large vessel occlusion: a MR CLEAN Registry substudy.J Neurointerv Surg. 2023 Nov;15(e2):e255-e261. doi: 10.1136/jnis-2022-019670. Epub 2022 Nov 15. J Neurointerv Surg. 2023. PMID: 36379704
-
Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.Neurology. 2023 Feb 14;100(7):e739-e750. doi: 10.1212/WNL.0000000000201537. Epub 2022 Nov 9. Neurology. 2023. PMID: 36351814 Free PMC article.
-
Sex disparity in stroke outcomes in a multicenter prospective stroke registry in Vietnam.Int J Stroke. 2023 Oct;18(9):1102-1111. doi: 10.1177/17474930231177893. Epub 2023 Jun 1. Int J Stroke. 2023. PMID: 37190749 Review.
-
Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?World Neurosurg. 2014 Sep-Oct;82(3-4):e453-8. doi: 10.1016/j.wneu.2013.01.097. Epub 2013 Feb 1. World Neurosurg. 2014. PMID: 23376392 Review.
Cited by
-
Quality of care for acute ischemic stroke in China during the COVID-19 pandemic: a retrospective study using a National database.BMC Public Health. 2025 Aug 2;25(1):2621. doi: 10.1186/s12889-025-23910-x. BMC Public Health. 2025. PMID: 40753201 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical